Last reviewed · How we verify

NCT04560530

The Role of CT Chest Scan in the Pre-anesthetic Assessment of Suspected or Confirmed COVID -19 Patients

Completed Last updated 23 September 2020
What this trial tests

trial testing Non-enhanced CT scan of the chest in Covid19 in 76 participants. Completed in 1 September 2020.

Timeline
1 March 2020
Primary endpoint
30 July 2020
1 September 2020

Quick facts

Lead sponsorTanta University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment76
Start date1 March 2020
Primary completion30 July 2020
Estimated completion1 September 2020
Sites1 location across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

18 and older, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The role of CT scan of the chest in Pre-anesthetic assessment of the severity of COVID-19 and the correlations between CT measurements of the aortic and pulmonary arteries diameters and severity of pneumonia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Is There a Role for Pre-Operative CT Chest Scans in Suspected COVID-19 Patients Requiring Emergent Surgery?: Insights from a Cross-Sectional Study
    Abosamak MF, Henry BM, Ali MF, Cirocchi R, et al · · 2021 · DOI 10.2139/ssrn.3802652

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04560530.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing